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When the term vaccine is mentioned during pregnancy, a spectrum of emotions 
may occur in patients. Many may experience feelings of fear, unsureness, anxiety, or lack 
of knowledge on the topic, while others experience a sense of relief, protection, self-
preservation, and safety. However, when a patient cannot access desired vaccines or 
experiences a lack of knowledge regarding the topic, those emotions may change. In the 
1920s and 1940s, many families in the United States experienced the loss of a loved one 
related to what are now considered preventable diseases, including diphtheria, polio, and 
measles (Healthy Children, 2015). Reportedly, in the early 20th century diphtheria 
claimed more than 10,000 lives a year in the United States while measles affected nearly 
a half million children (Healthy Children, 2015). The Centers for Disease Control and 
Prevention (CDC) reported that during the 20th Century, pertussis had a significant 
impact on childhood mortality rates in the US, and was labeled one of the most common 
childhood disease (CDC, 2020). Today, vaccinations are more widespread, however 
accessibility and lack of patient and provider education remain commonly reported 
barriers to their use. As access restrictions and a lack of education continue, pertussis has 
been—and continues—to be on the rise, with outbreaks continually occurring in the US. 
A 2017 CDC report notes that an average of 1,000 infants are hospitalized, and between 5 
to 15 infants die each year due to a pertussis infection (CDC, 2017). The resurgence and 
ongoing persistence of pertussis infections reinforces the need for increased vaccine 
education and accessibility.  
 
This study focused on the tetanus, diphtheria, and pertussis vaccine (Tdap). The 
Centers for Disease Control Advisory Committee (ACIP, 2020) recommends a single dose 
of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) with 
each pregnancy in order to reduce the pertussis incidence in infants, regardless of prior 
history of vaccination (CDC, 2020). The recommendation by the American College of 
Obstetricians and Gynecologists (ACOG, 2020) is the same, a single dose of Tdap for all 
pregnant women. The World Health Organization (WHO, 2015) reports the most effective 
means of preventing pertussis infections and decreasing mortality of infants too young to 
be vaccinated is vaccination during pregnancy. All three organizations endorse a single 
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dose of Tdap during each pregnancy and recommend that it be administered between 27 
and 36 weeks of gestation.  
 
 




In the United States in the 1920s, diphtheria claimed more than 10,000 lives a year 
(Healthy Children, 2015). In the 1940s, measles affected nearly half a million U.S. 
children, while polio impacted thousands (Healthy Children, 2015). The resurgences of 
pertussis infection in the United States has gained recent attention following a CDC 
(2021) study which reported 15,609 pertussis cases in 2018, a stark difference from the 
1,010 reported cases in 1976. Patient-reported barriers to vaccination include a lack of 
provider education on vaccine needs during pregnancy, thus leading to a lack of patient 
education on vaccines offered by providers during pregnancy. (Wiley et al., 2013). 
Inadequate patient education by providers has further created skepticism among patients 
regarding the need for vaccines during pregnancy (Wiley et al.). For decades, vaccine 
accessibility and education have been commonly reported barriers to vaccine use (Wiley 
et al.). The literature continues to suggest that variables currently exist which may act as 
barriers to vaccine uptake, and there is an immediate need for interventions to improve 




There is continued debate over the pros and cons of vaccination in the United 
States with some arguing that vaccinations are harmful, while others argue that they are 
a necessity (National Vaccine Information Center, 2016). In their 2012 article, Adegbola 
et al note that, “Infectious diseases remain the most important cause of childhood 
morbidity and mortality worldwide, accounting for two thirds of the estimated 8.8 million 
deaths in children aged less than 5 years in 2008” (p. S28). Vaccinations during 
pregnancy are often controversial or bothersome for patients and their families (National 
Vaccine Information Center, 2016). In studies, patients have reported multiple barriers 
to vaccination uptake during and outside of pregnancy, including lack of knowledge 
regarding vaccination safety or the importance of vaccinations during pregnancy, lack of 
vaccine discussion by providers, lack of access to vaccines, and lack of reminders for 
vaccine needs (Head, Vanderpool, & Mills). In his research into Tdap, Long found that 
“Pertussis cases have surged to more than 48,000 nationwide in 2012, exceeding the 
number of cases reported annually since the 1950s” (Long, 2014, p. 1). Tamma et al 
(2009) report that vaccination rates remain the lowest in the pregnant population, yet 
vaccinations continue to be “the most effective method for preventing severe influenza 
illness and its sequelae” (p. 547). In their research, Hibberd (2015) discussed vaccination 
statistics and noted that immunization rates remain unacceptably low for younger adults. 
Hibberd recommends strategies to improve vaccination rates, including the use of safe, 
dual vaccine administration, and the responsibility of health care professionals to ensure 
proper reporting. Other suggested strategies to increase vaccine uptake include 
addressing patient and provider concerns of vaccine safety, improvement of vaccination 
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delivery systems, and taking advantage of vaccination opportunities during all health care 
visits (Hibberd).  
 
ACCESS TO CARE/EDUCATION  
 
Wilson, Paterson, Jarrett and Larson (2015) studied factors influencing 
vaccination acceptance during pregnancy, and noted that the main barriers include: 
vaccination safety, not recommended by the healthcare provider, low knowledge about 
vaccines, access issues, cost, and conflicting advice. Eilers, Krabbe, and Melker (2015) 
completed a literature review to assess factors related to poor vaccine uptake in the 
population. Six themes influencing vaccine uptake were identified: attitudes and beliefs, 
perceived risk, complete knowledge of the vaccine, education from health care workers, 
accessibility and affordability (Eilers et al.). In their 2014 Cochran database review of 
Randomized Controlled Trials (RCT), Thomas and Lorenzetti studied interventions to 
increase influenza vaccine uptake in people aged 60 and older. The study analyzed 57 
RCTs with 896,531 participants and found themes/gaps affecting vaccine use, including:  
access to care, cost of vaccine, and patient education regarding the influenza vaccine. 
Recommendations to improve vaccination rates included enhancing vaccine access, 
providing patient reminders, and increasing education to patients and providers (Thomas 




In 2014, WHO completed a research study on immunization, vaccines and 
biologicals focused on pertussis disease, discussing how the virus is spread, signs and 
symptoms, causative agent, and related statistics. The report confirmed the purpose of 
the pertussis vaccine is to reduce the risk of severe pertussis in infancy: “WHO estimates 
that in 2008, global vaccination against pertussis prevented approximately 687,000 
deaths” (WHO, 2014). The report further recommended treating all hospital staff, 




The objective of this study was to assess whether there was an effect on maternal Tdap 
vaccine utilization rates when common barriers (e.g., lack of education or decreased access) were 
rectified. The pre- vs. post-intervention study was conducted at a 52-bed north Georgia 
hospital that sees approximately 350 deliveries annually (Piedmont Health Care, 2016). 
To determine the study sample size, the researcher conducted a power analysis for a one 
sided McNemar test, using a power (1-β) of .80 and an α (Type I error) of .05. The analysis 
indicated a minimum sample size of 18 needed to detect a significant improvement in 
vaccination rates of at least 45% before and after the educational intervention. To allow 
for the detection of smaller changes in vaccination rates, the researcher chose a sample of 
20. The 20 participants were selected from the prior admission log over a two-week 
admission period using a random numbers tables. 
During their antepartum period, participants were contacted via phone and an 
interviewer administered the “Vaccination and Barriers” section of the Pregnancy Risk 
Assessment Monitoring System (PRAMS) questionnaire. Immediately following the 
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questionnaire, participants were provided with education on the importance getting a 
Tdap vaccine during pregnancy, and were notified that their obstetrician’s office could 
provide the vaccine. After delivery, postpartum data was gathered via a second 
interviewer-administered PRAMS questionnaire prior to the patient's discharge home 
from the hospital.  
 
The two independent variables of interest were (1) access to Tdap vaccine and (2) 




DATA ANALYSIS PROCEDURES 
 
All data was analyzed using SPSS (v.21). Vaccination status was coded as 1 
(vaccinated) or 0 (not vaccinated) for each of the two stages of the study: antepartum and 
postpartum. Data was categorical, and the descriptive analysis performed included an 
examination of counts and percentages of survey responses. The researcher chose the 
McNemar test to assesses if a statistically significant change in proportions occurred on a 
dichotomous trait (vaccination status) at two time points on the same population 
(antepartum and postpartum). The McNemar analysis aligns well with the correlational 
design of the study, which aimed to detect whether the intervention (educational call) was 







The descriptive statistics are followed by the discussion of the results from the 
McNemar tests. 
 
Descriptive Statistics. The results for antepartum participants are provided in Figures 
1 and 2. Figure 1 depicts the results of Question #1, which study participants answered 
prior to delivery of their infant. The results show that all 20 participants (antepartum) 













The data presented in Figure 1 and Figure 2 provide a reference point for the data obtained 
from antepartum participants and was compared with the data obtained from postpartum 
participants in Figure 3 and Figure 4.  
 
The results from the postpartum administration of the PRAMS questionnaire are 
provided in Figure 3 and Figure 4. Figure 3 depicts the results of the postpartum 
participants answer to Question #1; fifteen of the 20 participants reported having received 
the Tdap vaccine after being provided vaccine education and information on how to access 
the Tdap vaccine. 
 



























Figure 4 depicts the various answers received from the postpartum participants. 
 
The categories presented in Figure 4 reflect the response options included in the PRAMS 
questionnaire or Question # 2: 
 
A= I received the Tdap vaccine before I got pregnant with my new baby  
B= I received the Tdap vaccine after my new baby was born 
C= My health care provider did not offer or recommend it  
D= My health care provider did not have the vaccine 
E= I don’t like to get vaccinated 
F= I don’t think the vaccine is safe during pregnancy 
G= I don’t think the vaccine is safe while nursing my baby  
H= I am worried about the side effects of the vaccine 
I= Other → Please tell us:   ______________________ 
 
The data shows a positive correlation between the intervention (patient education 
telephone calls and improved accessibility) with patient Tdap vaccine utilization rates. 
Postpartum, 15 out of 20 participants reported having received the Tdap vaccine.  
 
 
Results of McNemar Tests. In order to conduct the McNemar statistical test for the first 
clinical question, data were organized in a 2x2 contingency table. This section presents the 
results of the McNemar tests, separately for each clinical question. 
 
McNemar tests are nonparametric tests that allow principal investigators to assess change 
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question, the McNemar test determines whether the difference in vaccination rates varies 
significantly before and after the intervention (educational telephone calls and increased 
accesibility). Before conducting the McNemar test for this question, the data obtained 
through the PRAMS questionnaire were organized in a 2x2 contingency table (see Table 
1), where the cells contain frequencies of outcomes. Four outcomes are summarized in 
the table: received vaccination before delivery (Antepartum-Y), did not receive 
vaccination before delivery (Antepartum-N), received vaccination after delivery 
(Postpartum-Y), and did not receive vaccination after delivery (Postpartum-N). 
 
The information presented in the first row captures the following mutually exclusive 
groups: number of subjects who received the Tdap vaccination neither before nor after 
delivery (5); number of subjects who were not vaccinated antepartum but received the 
vaccine after delivery (15), and the total number of subjects who were not vaccinated 
before delivery. Similarly, the second row breaks down the number of subjects who were 
vaccinated before delivery (0) by their vaccination status after delivery. Since no subjects 
received the vaccine before delivery, all cells in the second row are 0. As the table 
indicates, none of the 20 participants received Tdap immunization during pregnancy, 
before the calls were made (0% vaccination rate). Following the educational calls, 15 of 
the 20 participants reported that they were vaccinated (75% vaccination rate) after 
delivery. 
 
Table 1. Contingency Table for McNemar Analysis: Tdap Vaccination Rates Before 
and After Intervention 
 
 Postpartum-N Postpartum-Y Total 
Antepartum-N 5 15 20 
Antepartum-Y 0 0 0 




Table 2 captures the results of the McNemar test: The Chi-Square statistic, which tests for 
the equality of vaccination rates between the two points in time (antepartum and 
postpartum); the total number of subjects included in the test (n=20), degrees of freedom 
for the McNemar test, which is the number of time points being compared minus one (2- 
1=1); and the p value or the significance level for the test, which represents how likely the 
result found would occur by chance. Specifically, there is only a 2.5% probability (p = 
.025) that the difference we found in vaccination rates before and after the intervention 
may have been due to chance or other factors. In other words, we can say that if we were 
to repeat this study with different samples, the observed difference in vaccination rates 
would be expected to occur by chance only 2.5 in 100 times in repeated tests on different 
samples of the population of pregnant women. As with any other Chi-Squared test, a p 
value for the McNemar test that is less than .05 indicates that the difference between 
antepartum and postpartum vaccination rates was statistically significant at the .05 level. 
 
The results of the test (see Table 2) indicate that the rate of vaccination differs 
significantly before and after the educational-based telephone calls (χ²(1,20)= 5.00, p 
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=.025). That is, the antepartum to postpartum increase in vaccination rates from 0% to 
75% was statistically significant at the .05 level. 
 
Table 2. McNemar Test Results for Clinical Question 1 
 
Statistic Value 





To allow the calculation of the McNemar’s Chi-Squared, data were organized in a 2x2 
contingency table (see Table 3), displaying in rows the number of patients who had/did 
not have access to the Tdap vaccine in their obstetrician’s office before delivery (Yes or 
No) while the columns indicated the postpartum vaccination status (Yes or No). A total of 
13 participants responded that they were either not offered or recommended the vaccine 
by their obstetrician (response c), or that their obstetrician’s office did not have the 
vaccine (response d). All 13 participants in this group (100%) reported that they received 
the vaccine after their baby was born. Seven participants reported that they had access to 
the vaccine before delivery, but that they refused to receive immunization due to various 
reasons. Most of the reported reasons can be related to lack of education about the 
vaccine, even after the principal investigators educational calls: E= I don’t like to get 
vaccinated, F= I don’t think the vaccine is safe during pregnancy, G= I don’t think the 
vaccine is safe while nursing my baby, H= I am worried about the side effects of the 
vaccine, I= Other. Only two of these seven participants (29%) received vaccination after 
their baby was born. 
 
 
Table 3. Contingency Table for McNemar Analysis: Effect of Access to 
Vaccine on Tdap Vaccination Rates 
 
Postpartum Vaccination Total 
Antepartum Access to Vaccine in 
Obstetrician Office 
No Yes  
No 0 13 13 
Yes 5 2 7 
Total 5 15 20 
 
 
Table 4 displays the results of the McNemar test and reports the following numbers: Total 
number of subjects included in the test (n=20); degrees of freedom for the McNemar test, 
which is the number of groups of subjects being compared minus one (2- 1=1); and the p 
value or significance level for the test (p = .059), which indicates that if we were to repeat 
this study with different samples, the observed difference in vaccination rates would be 
expected to occur by chance 6 in 100 times in repeated tests on different samples of the 
population of pregnant women. In other words, there is a 6% probability that the 
difference we found in vaccination rates before the two groups was due to chance, and not 
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to being able to access the vaccine in the obstetrician’s office. 
 
The p value obtained for the Chi Square test is higher than .05, which means that the 
difference between the vaccination rates of the two groups was not statistically significant 
at .05. In the behavioral and social sciences, the conventional cutoff p values for 
statistically significant results are .05 or .01. To be significant at the .05 level, the 
McNemar Chi-Square statistic would have to be higher than 3.84. 
 
Therefore, the results of the McNemar test indicate that the difference in postpartum 
vaccination rates between the two groups—patients without access to the vaccine and 
patients who had access but refused to be vaccinated—was only marginally significant at 
the .10 level (χ²(1, 20)= 3.55, p = .059). 
 
Table 4. McNemar Test Results for Clinical Question 2 
 
Statistic Value 






Despite the marginal statistical significance obtained for the McNemar test (perhaps due 
to the small sample), it is clear from the contingency table (Table 3) that educational calls with 
information about access to the vaccine increased access to the vaccine, which subsequently led 
to an increase in vaccination rates from 0% to 100% for the patients who did not have access to 
the vaccine during pregnancy. The calls were less effective, however, for the seven patients who 
did have access to the vaccine during pregnancy, but refused to be vaccinated (29% vaccination 
rate). 
 
ASSUMPTIONS, LIMITATIONS, DELIMITATIONS 
 
The following assumptions were present in this study: 
 
1. It is assumed that there is an association between low vaccine utilization during 
pregnancy and a lack of education of patient regarding the importance of the Tdap 
vaccine during pregnancy. 
2. It is assumed that there is an association between low vaccination utilization 
during pregnancy and lack of accessibility to the vaccine. 
 
The limitations related to this study included (a) PRAMS data only being available for the 
20 participants in this study limiting it to only participants in the state of Georgia; (b) 
only patients at a single hospital located in Georgia were included in this study; and (c) 





Delimitations recognized in this study included: 
 
1. There was no discussion of other vaccines that are recommended during 
pregnancy included in this study. The educational phone calls and follow up 
surveys only included education related to the Tdap vaccine. 
2. There was no review or discussion of barriers to vaccine utilization other than lack 
of education and lack of accessibility included in this study. 
3. There was no inclusion of pregnant participants outside of a north Georgia hospital 





The significance of this study is the protection of mothers and their newborns from 
potentially life-threating diseases or their sequelae. Information regarding the Tdap 
vaccine and its accessibility options may allow patients an opportunity to make a more 
informed decision. By identifying possible barriers and solutions related to poor vaccine 
utilization rates during pregnancy, practice improvements may be made. McCarthy et al 
(2012) described the influenza vaccine as being effective in preventing serious maternal 
and infant respiratory illness. This study only focused on the Tdap vaccine. However, 
literature provided throughout the study mentioned other recommended vaccines for the 
purpose of aiding in statistical validation for the Tdap vaccine and the possible related 
barriers to underutilization of the vaccine. 
 
The Tdap vaccine is comprised of three different components, thus giving it the ability to 
protect against three different diseases—tetanus, diphtheria, and pertussis (CDC, 2015). 
However, the only way the vaccine can protect patients and their newborns is if they 
receive the vaccine. Health care professionals must not be stagnant in efforts to improve 
patient outcomes. If changes are not made in practice, patients and their families are at 
risk for possible life-threating sequela related to vaccine-preventable disease. When 
vaccinations are not obtained during pregnancy, both pregnant women and their unborn 
child or children can suffer serious sequel (Kalan et al., 2014). By remaining vigilant in 
efforts to improve vaccine uptake, health care professionals can significantly influence 
not only patients, but the health care system as a whole. 
 
The information obtained during the study can be transferred to providers and used in 
hospital-based or community-based settings to increase vaccination uptake. With the 
continued exploration of possible barriers, information can be gained that will allow for 
changes in education or access to the Tdap vaccine, as needed. For example, if education 
and accessibility are proven to be barriers, methods to increase patient education and 
accessibility will be assessed and suggested. The literature and evidence presented 
throughout this study substantiate the need for additional research into vaccine 
utilization, and possible related barriers. 
 
The implications for this study include two changes in practice: (1) provide pregnant 
patients with education on the safety and necessity of Tdap vaccine, and (2) provide 
patients with information on where they can receive a Tdap vaccine. The benefits of such 
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a change have the potential to decrease reported cases of pertussis and tetanus, especially 




The study findings indicate that improved accessibility and improved patient 
education on Tdap vaccine can make a substantial difference in vaccine utilization rates 
among pregnant patients. Although the study showed statistical significance, more 
importantly, it showed clinical significance. The findings contribute to the literature on 
the correlation between patient education and access to vaccines, and vaccine use rates, 
as well as provide recommendations for possible improvements to further increase Tdap 
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